OSE Immunotherapeutics Stock Deutsche Boerse AG
Stocks
6OP
FR0012127173
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.164 EUR | -1.31% |
|
0.00% | -39.62% |
| 06-11 | OSE Immunotherapeutics Recovers Following Oddo BHF Endorsement |  |
| 06-10 | OSE Immunotherapeutics SA - Special Call |
| Market Cap | 78.32M 90.55M 73.14M 67.1M 126M 8.62B 128M 858M 337M 4.32B 340M 333M 14.28B | P/E 2026 * |
-2.56x | P/E 2027 * | -2.93x |
|---|---|---|---|---|---|
| Enterprise Value | 119M 138M 111M 102M 192M 13.11B 195M 1.31B 512M 6.57B 517M 506M 21.72B | EV / Sales 2026 * |
24.3x | EV / Sales 2027 * | 13.4x |
| Free-Float |
78.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: OSE Immunotherapeutics
| 1 day | -1.31% | ||
| 1 month | -9.96% | ||
| 3 months | -24.67% | ||
| 6 months | -28.42% | ||
| Current year | -39.62% |
| 1 week | 3.11 |  | 3.21 |
| 1 month | 3.09 | | 3.34 |
| Current year | 2.86 | | 5.57 |
| 1 year | 2.86 | | 7.16 |
| 3 years | 2.7 | | 10.68 |
| 5 years | 2.7 | | 13.5 |
| 10 years | 2.7 | | 15.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Bozec
CEO | Chief Executive Officer | - | 2025-10-01 |
Thomas Gidoin
DFI | Director of Finance/CFO | 43 | 2025-08-19 |
Silvia Comis
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Maryvonne Hiance
BRD | Director/Board Member | 77 | 2016-05-30 |
Brigitte Dreno
BRD | Director/Board Member | 73 | 2017-06-13 |
| Director/Board Member | - | 2023-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.31% | 0.00% | - | - | 90.55M | |
| +0.99% | +1.78% | +4.07% | +16.73% | 49.47B | |
| +3.71% | +9.40% | +486.98% | +592.14% | 43.61B | |
| +5.60% | +10.21% | +16.76% | +85.72% | 39.6B | |
| +2.70% | +1.57% | +33.39% | +8.85% | 39.29B | |
| +2.21% | +6.75% | +21.31% | +53.37% | 32.43B | |
| +2.23% | +4.71% | - | - | 16.84B | |
| +0.97% | +2.35% | +37.75% | +126.84% | 16.49B | |
| -0.11% | +2.41% | +6.24% | +18.87% | 14.01B | |
| +0.75% | +15.04% | +78.59% | +30.30% | 12.77B | |
| Average | +1.77% | +6.32% | +85.64% | +116.60% | 29.39B | |
| Weighted average by Cap. | +2.54% | +6.10% | +104.25% | +140.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.9M 5.66M 4.58M 4.2M 7.9M 539M 8.02M 53.69M 21.07M 270M 21.27M 20.81M 893M | 10.53M 12.17M 9.83M 9.02M 16.97M 1.16B 17.24M 115M 45.28M 581M 45.71M 44.71M 1.92B |
| Net income | -30.59M -35.36M -28.56M -26.2M -49.28M -3.37B -50.07M -335M -132M -1.69B -133M -130M -5.58B | -21.47M -24.82M -20.05M -18.39M -34.59M -2.36B -35.14M -235M -92.32M -1.18B -93.19M -91.15M -3.91B |
| Net Debt | 40.79M 47.16M 38.09M 34.94M 65.73M 4.49B 66.77M 447M 175M 2.25B 177M 173M 7.44B | 63.08M 72.93M 58.91M 54.04M 102M 6.94B 103M 691M 271M 3.48B 274M 268M 11.5B |
| Date | Price | Change |
|---|---|---|
| 26-08-07 | €3.164 | -1.31% |
| 26-08-06 | €3.206 | +1.39% |
| 26-08-05 | €3.162 | +1.74% |
| 26-08-04 | €3.108 | -1.71% |
| 26-08-03 | €3.162 | -0.06% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSE Stock
- 6OP Stock
Select your edition
All financial news and data tailored to specific country editions
